Second-Order Derivative UV Spectrophotometric and RP-HPLC Methods for the Analysis of Vildagliptin and Application for Dissolution Study
DOI:
https://doi.org/10.22456/2527-2616.86511Keywords:
Vildagliptin, Derivative UV Spectrophotometry, HPLC, Dissolution Method, ValidationAbstract
This study describes two analytical methods, by second-order derivative UV spectrophotometric by HPLC, for determination of vildagliptin, a drug used for treatment of type 2 Diabetes Mellitus that belongs to a therapeutic class called inhibitors of dipeptidyl peptidase 4. The methods were validated in accordance with ICH and USP requirements. Analyses by UV derivative method were performed at 220 nm, which was the zero crossing point of excipient solutions. HPLC was optimized and the analysis was carried out using a Zorbax Eclipse Plus RP-C8 column (150 mm × 4.6 mm, 5 μm), detection at 207 nm, and potassium phosphate buffer solution pH 7.0 : acetonitrile (85:15, v/v) as mobile phase. In dissolution test, the conditions used were 0.01 mol L-1 hydrochloric acid in 900 mL of dissolution medium, USP apparatus 2 (paddle) and 50 rpm stirring speed. Both methods were successfully applied for analysis of dissolution samples from marketed vildagliptin tablets.
Downloads
References
Mathieu, C; Diabetes, Obesity and Metabolism, 2009, 11(2): 9–17.
Srinivasan, B.T., Jarvis, J., Khunti, K. and Davies, M.J.; Postgraduate Medical Journal, 2008, 84: 524-531.
Kahn, S.E., Haffner, S.M., Heise, M.A., Herman, W.H., Holman, R.R. and Jones, N.P.; New England Journal of Medicine, 2006, 355: 2427-2443.
Del, P.S., Bianchi, C. and Marchetti, P.; Diabetes & Metabolism, 2007, 23; 518-527.
Bolli, G., Dotta, F., Colin, L., Minic, B. And Goodman, M.; Diabetes, Obesity and Metabolism, 2009, 11: 589–595.
Kamberi, M. and Tran, T.; Journal of Pharmaceutical and Biomedical Analysis, 2012, 70: 94-100.
Food and Drug Administration; Guidance for industry: immediate release solid oral dosage forms: scale-up and post-approval changes, U. S. Department of Health and Human Services, Center for Drug Evaluation and Research, Rockville, USA, 1995.
Rozet, E., Ziemonsa, E., Marinia, R.D., Boulanger, B. and Hubert, P.; Analytica Chimica Acta, 2012, 751: 44–51.
Tomsu, D., Catalá Icardo, M. and Martínez Calatayud, J.; Journal of Pharmaceutical and Biomedical Analysis, 2004, 36: 549– 557.
Gorog, S.; Analytical Sciences, 2004, 20(5): 767-782.
Karpinska, J.; Talanta, 2004, 64: 801-822.
El-Sayed, A.Y. and El-Salem, N.A.; Analytical Sciences, 2005, 21(6): 595-614.
Rojas, F. and Ojeda, C.; Analytica Chimica Acta, 2009, 635: 22–44.
The United States Pharmacopoeia, USP 39, United States Pharmacopeial Convention, Rockville, USA, 2016.
International Conference on Harmonization; ICH Guideline Q2(R1): Validation of Analytical Procedures: Text and Methodology, Geneva, Switzerland, 2005.
Sznitowska, M. and Stokrocka, M.; Acta Poloniae Pharmaceutica-Drug Research, 2007, 63(5): 401-405.
Barden, A.T., Salamon, B., Schapoval, E.E.S. and Steppe, M.; Journal of Chromatographic Science, 2012, 50: 426– 432.
Downloads
Published
Versions
- 11-03-2026 (3)
- 08-03-2026 (2)
- 14-09-2018 (1)
How to Cite
Issue
Section
License
Copyright (c) 2018 Drug Analytical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Licensing:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.
